Together we will beat cancer

Donate

Cancer Research UK spin-out gets US approval to trial unique T cell therapy

Cancer Research UK’s spin-out, GammaDelta Therapeutics, has been given approval to trial its unique T-cell therapy in the US.  

Read More

Combination immunotherapy for advanced bowel cancer approved for NHS in England

People who have previously been treated for a type of bowel cancer that has spread to other parts of their body will now have another treatment option in England.

Read More

ASCO 2021 news: follow-up treatments pave the way

One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented.

Read More

New hormone treatment for advanced prostate cancer made available in England

Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England.

Read More

Common anti-inflammatory drug could boost cancer immunotherapy

Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery.

Read More

Opinion: ‘Wales needs more than a three-page statement to get cancer services back on track’

The Welsh Government’s decision to publish just a short statement on how it intends to improve patient care over the next 5 years is unacceptable.

Read More

Could proton beam therapy improve throat cancer treatment?

The first proton beam therapy clinical trial in the UK is finding out if this innovative new form of radiotherapy can improve throat cancer treatment.

Read More

2,000 fewer people in England began cancer treatment in January

The latest cancer waiting times show an 8% drop in the number of people starting cancer treatment in January, compared with figures from January 2020.

Read More

Potentially life-extending treatment for lung cancer available in England

A potentially life-extending treatment for some people with non small cell lung cancer (NSCLC) will now be available on the NHS in England.

Read More

Cancer services during COVID-19: 40,000 fewer people starting treatment

There’s been a steady stream of figures since the pandemic began, each laying bare what many people have seen first-hand – the impact on health services.

Read More